Eric L. Sievers MD

Dr. Eric Sievers, MD, is Chief Medical Officer at Trillium Therapeutics, Inc., a Member at The European Hematology Association, a Member at American Society of Hematology, a Member at American Society of Clinical Oncology, and a Member at American Association for Cancer Research.

Dr. Sievers was previously employed as Senior Vice President-Clinical Development by Seattle Genetics, Inc. and Medical Director by ZymoGenetics, Inc. He received his undergraduate degree from Brown University and a doctorate degree from Brown University.